| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.36 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |